Citalopram NDC 70518-2601

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-2601Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-2601Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-2601-1	70518260101	100 POUCH in 1 BOX (70518-2601-1) / 1 TABLET, FILM COATED in 1 POUCH (70518-2601-2)Marketed from Apr 16, 2020
70518-2601-3	70518260103	30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2601-3)Marketed from Apr 16, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Citalopram
Generic name (nonproprietary): citalopram
Active ingredients: Citalopram hydrobromide — 40 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077042
Marketing start: Feb 26, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 70518-2601_579a40e5-ed64-65b2-e063-6394a90acec1SPL ID 579a40e5-ed64-65b2-e063-6394a90acec1SPL set ID aa9c1440-354f-43a6-9e70-fd7bafcb03c5RxCUI 309314UNII I1E9D14F36
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518260101 followed by a unit qualifier and the quantity

Package 70518-2601-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ] . Citalopram tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ) .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077042

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077042
Product	Strength	Form · route	Labeler	Product NDC
Citalopram	Citalopram hydrobromide 10 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-6231
Citalopram	Citalopram hydrobromide 20 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-6232
Citalopram	Citalopram hydrobromide 40 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-6233
Citalopram	Citalopram hydrobromide 40 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2232
Citalopram	Citalopram hydrobromide 10 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-2553
Citalopram	Citalopram hydrobromide 40 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals,Inc.	68071-3558